Camptothecin and mitomycin combination chemotherapy on ovarian clear cell carcinoma with multiple systemic metastases

被引：0
|
作者：
Tanaka, T [1 ]
Umesaki, N [1 ]
Ogita, S [1 ]
机构：
[1] Osaka City Univ, Sch Med, Dept Obstet & Gynecol, Abeno Ku, Osaka 5458585, Japan
来源：
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | 2000年 / 21卷 / 04期
关键词：
camptothecin; mitomycin; clear cell carcinoma; ovary; chemotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ovarian clear cell carcinoma is known for decreased responsiveness to most anticancer drugs, and the prognosis of patients with ovarian clear cell tumors is very poor. We report such a patient with multiple systemic metastases who showed a complete response to combined camptothecin and mitomycin chemotherapy. During therapy, clinical drug-resistance was observed transiently, but response was restored by intermittent administrations of camptothecin. Such combination chemotherapy may be a useful alternative regimen for advanced and/or metastatic ovarian clear cell carcinoma.
引用
收藏
页码：377 / 379
页数：3
相关论文
共 50 条
  • [21] Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report
    Takatori, Eriko
    Shoji, Tadahiro
    Miura, Yuki
    Takada, Anna
    Takeuchi, Satoshi
    Sugiyama, Toru
    ONCOTARGETS AND THERAPY, 2014, 7 : 165 - 168
  • [22] Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomes
    Nasioudis, Dimitrios
    Mastroyannis, Spyridon A.
    Albright, Benjamin B.
    Haggerty, Ashley F.
    Ko, Emily M.
    Latif, Nawar A.
    GYNECOLOGIC ONCOLOGY, 2018, 150 (01) : 14 - 18
  • [23] Complete remission of recurrent ovarian clear cell carcinoma by chemotherapy with bevacizumab, trabectedin and oxaliplatin
    Takano, Masashi
    Ikeda, Yuji
    Kudoh, Kazuya
    Kita, Tsunekazu
    Sasaki, Naoki
    Kikuchi, Yoshihiro
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2013, 39 (04) : 872 - 875
  • [24] OVARIAN CLEAR-CELL CARCINOMA ASSOCIATED WITH MULTIPLE DISTINCT MULLERIAN TUMORS
    VANBOGAERT, LJ
    DEMUYLDER, E
    STAQUET, JP
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1976, 6 (06): : 301 - 307
  • [25] Combination lenvatinib plus pembrolizumab in the treatment of ovarian clear cell carcinoma: A case series
    Calo, Corinne A.
    Levine, Monica D.
    Brown, Morgan D.
    O'Malley, David M.
    Backes, Floor J.
    GYNECOLOGIC ONCOLOGY REPORTS, 2023, 46
  • [26] COMBINATION CHEMOTHERAPY OF ADVANCED OVARIAN-CARCINOMA
    KLEINMANNS, G
    DAUER, W
    KNIEF, JJ
    WESTERHAUSEN, M
    ONKOLOGIE, 1983, 6 (04): : 206 - 209
  • [27] DOXORUBICIN COMBINATION CHEMOTHERAPY IN OVARIAN-CARCINOMA
    BUNDY, BN
    OMURA, GA
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (04) : 680 - 681
  • [28] COMBINATION CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA
    AMADORI, D
    RAVAIOLI, A
    MALTONI, M
    RIDOLFI, R
    GENTILINI, P
    GIUNCHI, DC
    FRASSINETI, L
    FALCINI, F
    AMADORI, M
    TUMORI, 1986, 72 (05) : 519 - 524
  • [29] COMBINATION CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA
    HOCHSTER, H
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (07) : 1148 - 1148
  • [30] COMBINATION CHEMOTHERAPY OF OVARIAN-CARCINOMA WITH CAP
    GRIFFIN, JP
    BELINSON, J
    LYNN, J
    MYERS, RA
    VALENTINE, J
    STEWART, J
    GOLDBERG, R
    YATES, J
    KRAKOFF, IH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 468 - 468
12345